Nuclear Medicine, Centre Antoine Lacassagne, University Hospital, Université de Nice Sophia Antipolis, Nice, France
Department of Nuclear Medicine, Academic Medical Center AMC, Amsterdam, Netherlands
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, Stockholm, Sweden
Nuclear Medicine Division, Université Catholique de Louvain Medical Center, Mont-Godinne Medical Center, Louvain-la-Neuve, Belgium
Clinical Neurophysiology Unit, San Martino Hospital, University of Genova, Genova, Italy
Psychiatry, Department of Mental Health Sciences, University College London, London, United Kingdom
Division of Nuclear Medicine, University Hospital Leuven, Leuven, Belgium
Faculté de Médecine, Université de Nice, 28 avenue de Valombrose, Nice cedex 02 06107, France
Facult de M decine, Universit de Nice, 28 avenue de Valombrose, Nice cedex 02 06107, France
References: Tatsch, K., Asenbaum, S., Bartenstein, P., Catafau, A., Halldin, C., Pilowsky, L.S., European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands (2002) Eur J Nucl Med Mol Imaging, 29 (10), pp. 30-BP35. , 1:STN:280:DC%2BD38nntl2rtQ%3D%3D 1243649
Bartenstein, P., Grunwald, F., Kuwert, T., Tatsch, K., Sabri, O., Benkert, O., Fahlbusch, R., Weiller, C., Clinical applications of single photon emission tomography in neuromedicine: Part 1: Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease (2000) NuklearMedizin, 39 (7), pp. 180-195
Payoux, P., Baulieu, J.L., Darcourt, J., Guedj, E., Habert, M.O., Prunier, C., Guide pour la rédaction de protocoles pour la scintigraphie à l'aide de ligands des transporteurs présynaptiques de la dopamine dans le striatum (2008) Médecine Nucléaire, 32, pp. 623-625. , 10.1016/j.mednuc.2008.06.007
Catafau, A.M., Brain SPECT of dopaminergic neurotransmission: A new tool with proved clinical impact (2001) Nuclear Medicine Communications, 22 (10), pp. 1059-1060. , DOI 10.1097/00006231-200110000-00001
Halldin, C., Gulyas, B., Langer, O., Farde, L., Brain radioligands - State of the art and new trends (2001) Q J Nucl Med, 45 (2), pp. 139-152. , 1:STN:280:DC%2BD3MvivVGhtw%3D%3D 11476163
Tatsch, K., Imaging of the dopaminergic system in parkinsonism with SPET (2001) Nuclear Medicine Communications, 22 (7), pp. 819-827. , DOI 10.1097/00006231-200107000-00015
http://www.emea.europa.eu/humandocs/Humans/EPAR/datscan/Datscan.htm, DaTSCAN European Public Assessment Report. 072200en6.pdf and DaTSCAN-H-266-AR-II.pdfBenamer, H.T.S., Patterson, J., Grosset, D.G., Booij, J., De Bruin, K., Van Royen, E., Speelman, J.D., Ries, V., Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [ 123I]-FP-CIT study group (2000) Movement Disorders, 15 (3), pp. 503-510. , DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>
3.0.CO
Booij, J., Hemelaar, T.G., Speelman, J.D., De Bruin, K., Janssen, A.G., Van Royen, E.A., One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT (1999) J Nucl Med, 40 (5), pp. 753-761. , 1:CAS:528:DyaK1MXjsVamur8%3D 10319746
Scherfler, C., Schwarz, J., Antonini, A., Grosset, D., Valldeoriola, F., Marek, K., Oertel, W., Poewe, W., Role of DAT-SPECT in the diagnostic work up of Parkinsonism (2007) Movement Disorders, 22 (9), pp. 1229-1238. , DOI 10.1002/mds.21505
Vlaar, A.M.M., Van Kroonenburgh, M.J.P.G., Kessels, A.G.H., Weber, W.E.J., Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes (2007) BMC Neurology, 7, p. 27. , DOI 10.1186/1471-2377-7-27
McKeith, I., O'Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Reininger, C., Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study (2007) Lancet Neurology, 6 (4), pp. 305-313. , DOI 10.1016/S1474-4422(07)70057-1, PII S1474442207700571
O'Brien, J.T., Colloby, S., Fenwick, J., Williams, E.D., Firbank, M., Burn, D., Aarsland, D., McKeith, I.G., Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with lewy bodies (2004) Archives of Neurology, 61 (6), pp. 919-925. , DOI 10.1001/archneur.61.6.919
Walker, Z., Jaros, E., Walker, R.W.H., Lee, L., Costa, D.C., Livingston, G., Ince, P.G., Katona, C.L.E., Dementia with Lewy bodies: A comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy (2007) Journal of Neurology, Neurosurgery and Psychiatry, 78 (11), pp. 1176-1181. , DOI 10.1136/jnnp.2006.110122
Booij, J., Tissingh, G., Boer, G.J., Speelman, J.D., Stoof, J.C., Janssen, A.G., [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease (1997) J Neurol Neurosurg Psychiatry, 62 (2), pp. 133-140. , 10.1136/jnnp.62.2.133 1:STN:280:DyaK2s3gtVyrsQ%3D%3D 9048712
Marek, K.L., Seibyl, J.P., Zoghbi, S.S., Zea-Ponce, Y., Baldwin, R.M., Fussell, B., [123I]beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease (1996) Neurology, 46 (1), pp. 231-237. , 1:STN:280:DyaK287ktlWqtg%3D%3D 8559382
Marek, K., Innis, R., Van Dyck, C., Fussell, B., Early, M., Eberly, S., [123I]{beta}-CIT SPECT imaging assessment of the rate of Parkinson's disease progression (2001) Neurology, 57 (11), pp. 2089-2094. , 1:STN:280:DC%2BD3MjgtFCrsA%3D%3D 11739831
Booij, J., Kemp, P., Dopamine transporter imaging with [(123)I]FP-CIT SPECT: Potential effects of drugs (2008) Eur J Nucl Med Mol Imaging, 35 (2), pp. 424-438. , 10.1007/s00259-007-0621-0 1:CAS:528:DC%2BD1cXosVeisQ%3D%3D 17968545
Yang, Y.K., Yao, W.J., Yeh, T.L., Lee, I.H., Chen, P.S., Lu, R.B., Decreased dopamine transporter availability in male smokers-a dual isotope SPECT study (2008) Prog Neuropsychopharmacol Biol Psychiatry, 32 (1), pp. 274-279. , 10.1016/j.pnpbp.2007.08.018 1:CAS:528:DC%2BD1cXptlajug%3D%3D 17900774
Schillaci, O., Pierantozzi, M., Filippi, L., Manni, C., Brusa, L., Danieli, R., Bernardi, G., Stanzione, P., The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease (2005) European Journal of Nuclear Medicine and Molecular Imaging, 32 (12), pp. 1452-1456. , DOI 10.1007/s00259-005-1922-9
Fahn, S., Levodopa and the progression of Parkinson's disease (2004) New England Journal of Medicine, 351 (24), pp. 2498-2508+2566. , DOI 10.1056/NEJMoa033447
Varrone, A., Sansone, V., Pellecchia, M.T., Amboni, M., Salvatore, E., De Michele, G., Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [(123)I]FP-CIT (2008) Eur J Nucl Med Mol Imaging, 35 (7), pp. 1343-1349. , 10.1007/s00259-008-0729-x 18283454
Dobbeleir, A.A., Hambye, A.-S.E., Franken, P.R., Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: Consequences for imaging with 123I-labelled compounds in clinical practice (1999) European Journal of Nuclear Medicine, 26 (6), pp. 655-658. , DOI 10.1007/s002590050434
Koch, W., Hamann, C., Welsch, J., Popperl, G., Radau, P.E., Tatsch, K., Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies? (2005) J Nucl Med, 46 (11), pp. 1804-1811. , 16269593
Soret, M., Koulibaly, P.M., Darcourt, J., Hapdey, S., Buvat, I., Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT (2003) J Nucl Med, 44 (7), pp. 1184-1193. , 1:CAS:528:DC%2BD3sXmtF2msbY%3D 12843235
Habraken, J.B., Booij, J., Slomka, P., Sokole, E.B., Van Royen, E.A., Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm (1999) J Nucl Med, 40 (7), pp. 1091-1097. , 1:STN:280:DyaK1Mzjt1Sisw%3D%3D 10405125
Calvini, P., Rodriguez, G., Inguglia, F., Mignone, A., Guerra, U.P., Nobili, F., The basal ganglia matching tools package for striatal uptake semi-quantification: Description and validation (2007) European Journal of Nuclear Medicine and Molecular Imaging, 34 (8), pp. 1240-1253. , DOI 10.1007/s00259-006-0357-2
Kas, A., Payoux, P., Habert, M.-O., Malek, Z., Cointepas, Y., El Fakhri, G., Chaumet-Riffaud, P., Remy, P., Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images (2007) Journal of Nuclear Medicine, 48 (9), pp. 1459-1467. , DOI 10.2967/jnumed.106.038646
Koch, W., Radau, P.E., Hamann, C., Tatsch, K., Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies (2005) J Nucl Med, 46 (7), pp. 1109-1118. , 16000279
Booij, J., Sokole, E.B., Stabin, M.G., Janssen, A.G.M., De Bruin, K., Van Royen, E.A., Human biodistribution and dosimetry of [123I]FP-CIT: A potent radioligand for imaging of dopamine transporters (1998) European Journal of Nuclear Medicine, 25 (1), pp. 24-30. , DOI 10.1007/s002590050190
Kuikka, J.T., Bergstrom, K.A., Ahonen, A., Lansimies, E., The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane (1994) Eur J Nucl Med, 21 (1), pp. 53-56. , 10.1007/BF00182306 1:CAS:528:DyaK2cXlsFaiurc%3D 8088286
Seibyl, J.P., Wallace, E., Smith, E.O., Stabin, M., Baldwin, R.M., Zoghbi, S., Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects (1994) J Nucl Med, 35 (5), pp. 764-770. , 1:CAS:528:DyaK2cXlsFahtL0%3D 8176456
Catafau, A. M., Brain SPECT of dopaminergic neurotransmission: A new tool with proved clinical impact (2001) Nuclear Medicine Communications, 22 (10), pp. 1059-1060. , DOI 10. 1097/00006231-200110000-00001
http: //www. emea. europa. eu/humandocs/Humans/EPAR/datscan/Datscan. htm, DaTSCAN European Public Assessment Report. 072200en6. pdf and DaTSCAN-H-266-AR-II. pdfBenamer, H. T. S., Patterson, J., Grosset, D. G., Booij, J., De Bruin, K., Van Royen, E., Speelman, J. D., Ries, V., Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I] -FP-CIT SPECT imaging: The [123I] -FP-CIT study group (2000) Movement Disorders, 15 (3), pp. 503-510. , DOI 10. 1002/1531-8257 (200005) 15: 3<503:: AID-MDS1013>
3. 0. CO
Vlaar, A. M. M., Van Kroonenburgh, M. J. P. G., Kessels, A. G. H., Weber, W. E. J., Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes (2007) BMC Neurology, 7, p. 27. , DOI 10. 1186/1471-2377-7-27
O'Brien, J. T., Colloby, S., Fenwick, J., Williams, E. D., Firbank, M., Burn, D., Aarsland, D., McKeith, I. G., Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with lewy bodies (2004) Archives of Neurology, 61 (6), pp. 919-925. , DOI 10. 1001/archneur. 61. 6. 919
Marek, K. L., Seibyl, J. P., Zoghbi, S. S., Zea-Ponce, Y., Baldwin, R. M., Fussell, B., [123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease (1996) Neurology, 46 (1), pp. 231-237. , 1: STN: 280: DyaK287ktlWqtg%3D%3D 8559382
Yang, Y. K., Yao, W. J., Yeh, T. L., Lee, I. H., Chen, P. S., Lu, R. B., Decreased dopamine transporter availability in male smokers-a dual isotope SPECT study (2008) Prog Neuropsychopharmacol Biol Psychiatry, 32 (1), pp. 274-279. , 10. 1016/j. pnpbp. 2007. 08. 018 1: CAS: 528: DC%2BD1cXptlajug%3D%3D 17900774
Dobbeleir, A. A., Hambye, A. -S. E., Franken, P. R., Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: Consequences for imaging with 123I-labelled compounds in clinical practice (1999) European Journal of Nuclear Medicine, 26 (6), pp. 655-658. , DOI 10. 1007/s002590050434
Habraken, J. B., Booij, J., Slomka, P., Sokole, E. B., Van Royen, E. A., Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm (1999) J Nucl Med, 40 (7), pp. 1091-1097. , 1: STN: 280: DyaK1Mzjt1Sisw%3D%3D 10405125
Kuikka, J. T., Bergstrom, K. A., Ahonen, A., Lansimies, E., The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta- (4-iodophenyl) tropane (1994) Eur J Nucl Med, 21 (1), pp. 53-56. , 10. 1007/BF00182306 1: CAS: 528: DyaK2cXlsFaiurc%3D 8088286
Seibyl, J. P., Wallace, E., Smith, E. O., Stabin, M., Baldwin, R. M., Zoghbi, S., Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects (1994) J Nucl Med, 35 (5), pp. 764-770. , 1: CAS: 528: DyaK2cXlsFahtL0%3D 8176456
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M * The EEE project(449 views) Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980. Impact Factor:0 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote